Welcome to LookChem.com Sign In|Join Free
  • or
5-CHLORO-2,4-DINITROTOLUENE, also known as 5CDNT, is an organic compound that is primarily used as a chemical intermediate in the synthesis of various compounds. It is characterized by its molecular structure, which includes a chlorine atom at the 5th position and two nitro groups at the 2nd and 4th positions on a toluene ring.

51676-74-5

Post Buying Request

51676-74-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51676-74-5 Usage

Uses

1. Chemical Synthesis:
5-CHLORO-2,4-DINITROTOLUENE is used as a chemical intermediate for the synthesis of 5-methyl-6-nitrobenzofuroxan, a compound with potential applications in various industries.
2. Analytical Chemistry:
In the field of analytical chemistry, 5-CHLORO-2,4-DINITROTOLUENE is used for the development of molecular imprinted polymer (MIP) based electrochemical impedimetric sensors. These sensors have been found to have a low-detection-limit of 0.1μM for 5CDNT, making them highly sensitive and useful for detecting trace amounts of the compound in various samples.
3. Environmental and Industrial Applications:
Although not explicitly mentioned in the provided materials, 5-CHLORO-2,4-DINITROTOLUENE may also have potential applications in environmental monitoring and industrial processes due to its chemical properties. For instance, it could be used in the detection and analysis of pollutants or as a component in the manufacturing of certain chemicals or materials.

Check Digit Verification of cas no

The CAS Registry Mumber 51676-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,6,7 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 51676-74:
(7*5)+(6*1)+(5*6)+(4*7)+(3*6)+(2*7)+(1*4)=135
135 % 10 = 5
So 51676-74-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2O4/c1-4-2-5(8)7(10(13)14)3-6(4)9(11)12/h2-3H,1H3

51676-74-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L11808)  5-Chloro-2,4-dinitrotoluene, 97%   

  • 51676-74-5

  • 5g

  • 631.0CNY

  • Detail
  • Alfa Aesar

  • (L11808)  5-Chloro-2,4-dinitrotoluene, 97%   

  • 51676-74-5

  • 25g

  • 2522.0CNY

  • Detail
  • Aldrich

  • (553859)  5-Chloro-2,4-dinitrotoluene  97%

  • 51676-74-5

  • 553859-5G

  • 1,241.37CNY

  • Detail

51676-74-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-CHLORO-2,4-DINITROTOLUENE

1.2 Other means of identification

Product number -
Other names 5-Chloro-2,4-dinitrotoluene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51676-74-5 SDS

51676-74-5Relevant academic research and scientific papers

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

-

Paragraph 1786, (2015/09/22)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

-

, (2012/04/23)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Modulators of ATP-binding cassette transporters

-

Page/Page column 147, (2008/06/13)

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

Synthesis of the Food Mutagens MeIQx and 4,8-DiMeIQx by Copper(I) Promoted Quinoxaline Formation

Knapp, Spencer,Ziv, Joseph,Rosen, Joseph D.

, p. 1293 - 1298 (2007/10/02)

The regiocontrolled syntheses of the title compounds (1 and 2) is described.The key step is a new intramolecular alkyne amination and aromatization process (5 6; 8 9) effected by tetrakis(acetonitrile)copper(I) tetrafluoroborate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51676-74-5